{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:06:27Z","timestamp":1791378387163,"version":"4.3.2"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH\/NCI","doi-asserted-by":"publisher","award":["R01CA142840"],"award-info":[{"award-number":["R01CA142840"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH\/NCI","doi-asserted-by":"publisher","award":["R01CA129182"],"award-info":[{"award-number":["R01CA129182"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.radonc.2018.10.029","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T21:23:46Z","timestamp":1541712226000},"page":"213-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer"],"prefix":"10.1016","volume":"133","author":[{"given":"Jianxin","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3115-0637","authenticated-orcid":false,"given":"Jianyue","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Kalemkerian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Matuzsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Struti","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Ming (Spring)","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2018.10.029_b0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2018.10.029_b0010","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0360-3016(00)01401-2","article-title":"Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach","volume":"49","author":"Tyldesley","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.029_b0015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijrobp.2005.02.010","article-title":"High-dose radiation improved local tumor control and overall survival in patients with inoperable\/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study","volume":"63","author":"Kong","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.029_b0020","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2009.09.064","article-title":"Radiation-related heart disease: current knowledge and future prospects","volume":"76","author":"Darby","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.029_b0025","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.ijrobp.2009.04.093","article-title":"Radiation dose\u2013volume effects in the heart","volume":"76","author":"Gagliardi","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.029_b0030","doi-asserted-by":"crossref","first-page":"S592","DOI":"10.1016\/j.ijrobp.2012.07.1580","article-title":"High dose to large volumes of pericardium may be associated with radiation-related pericardial effusion and survival in patients with NSCLC","volume":"84","author":"Xue","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.029_b0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijrobp.2017.05.022","article-title":"Incidence and predictors of pericardial effusion after chemoradiation therapy for locally advanced non-small cell lung cancer","volume":"99","author":"Ning","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.029_b0040","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1200\/JCO.2016.70.0229","article-title":"Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy","volume":"35","author":"Wang","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0045","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.7501","article-title":"A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617. 2013 ASCO Annual Meeting. 31","author":"Bradley","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0050","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0055","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ijrobp.2011.12.032","article-title":"Are the results of RTOG 0617 mysterious","volume":"82","author":"Cox","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.029_b0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2017.09.004","article-title":"Heart dose associated with overall survival in locally advanced NSCLC patients treated with hypofractionated chemoradiotherapy","volume":"125","author":"Stam","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0065","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jtho.2016.09.134","article-title":"Heart dose is an independent dosimetric predictor of overall survival in locally advanced non-small cell lung cancer","volume":"12","author":"Speirs","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0070","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.radonc.2016.04.025","article-title":"Impact of heart and lung dose on early survival in patients with non-small cell lung cancer treated with chemoradiation","volume":"119","author":"Tucker","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejca.2017.07.053","article-title":"Radiation dose to heart base linked with poorer survival in lung cancer patients","volume":"85","author":"McWilliam","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2018.10.029_b0080","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1016\/j.ijrobp.2009.06.094","article-title":"Improving normal tissue complication probability models: the need to adopt a \u201cdata-pooling\u201d culture","volume":"76","author":"Deasy","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.029_b0085","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/j.ijrobp.2009.08.074","article-title":"The lessons of QUANTEC: recommendations for reporting and gathering data on dose\u2013volume dependencies of treatment outcome","volume":"76","author":"Jackson","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.029_b0090","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2007.10.056","article-title":"Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy","volume":"70","author":"Wei","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.029_b0095","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/annonc\/mdq042","article-title":"Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer","volume":"21","author":"Hardy","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0100","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(15)00021-2","article-title":"Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial","volume":"16","author":"Thatcher","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0105","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1200\/JCO.1994.12.6.1238","article-title":"Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer","volume":"12","author":"Fossella","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1200\/JCO.1995.13.2.531","article-title":"Myocardial ischemia and infarction associated with vinorelbine","volume":"13","author":"Bergeron","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0115","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/jjco\/hys099","article-title":"Gemcitabine-induced pleuropericardial effusion in a patient with pancreatic cancer","volume":"42","author":"Kido","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0120","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.4158\/EP11182.CR","article-title":"Erlotinib-associated exacerbation of hypothyroidism with pericardial tamponade","volume":"18","author":"Kastoon","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.radonc.2018.10.029_b0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000447053","article-title":"Nivolumab-induced pericardial tamponade: a case report and discussion","volume":"136","author":"Kushnir","year":"2017","journal-title":"Cardiology"},{"key":"10.1016\/j.radonc.2018.10.029_b0130","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2010.07.1977","article-title":"Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus","volume":"81","author":"Kong","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.029_b0135","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0360-3016(91)90794-5","article-title":"Pericarditis and myocardial infarctions after Hodgkin\u2019s disease therapy","volume":"21","author":"Cosset","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.029_b0140","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1001\/jama.1993.03510160067031","article-title":"Factors affecting late mortality from heart disease after treatment of Hodgkin\u2019s disease","volume":"270","author":"Hancock","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.radonc.2018.10.029_b0145","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1259\/0007-1285-69-825-839","article-title":"Long-term cardiac mortality after radiotherapy of breast cancer\u2013application of the relative seriality model","volume":"69","author":"Gagliardi","year":"1996","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2018.10.029_b0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0360-3016(97)00584-1","article-title":"Fraction size and dose parameters related to the incidence of pericardial effusions","volume":"40","author":"Martel","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.029_b0155","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.113.001435","article-title":"Long-term survival of patients with radiation heart disease undergoing cardiac surgery: a cohort study","volume":"127","author":"Wu","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.radonc.2018.10.029_b0160","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.radonc.2018.05.017","article-title":"Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer","volume":"128","author":"Contreras","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0165","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/j.ijrobp.2016.06.316","article-title":"Impact of incidental cardiac radiation on cardiopulmonary toxicity and survival for locally advanced non-small cell lung cancer: reanalysis of NRG oncology\/RTOG 0617 with centrally contoured cardiac structures","volume":"96","author":"Gore","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2018.10.029_b0170","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/annonc\/mdx069","article-title":"Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA\/B non-small-cell lung cancer: secondary analysis of a randomized trial","volume":"28","author":"Guberina","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0175","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2016.71.6142","article-title":"Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer","volume":"35","author":"Dess","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.radonc.2017.10.001","article-title":"Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer","volume":"125","author":"Wang","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2017.09.564","article-title":"MA 13.06 New risk factors for overall survival after SBRT in early stage NSCLC: a role of RT plan optimization","volume":"12","author":"Kong","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2018.10.029_b0190","article-title":"Higher radiation dose to immune system is correlated with poorer survival in patients with stage III non\u2013small cell lung cancer: A secondary study of a Phase 3 Cooperative Group Trial (NRG Oncology RTOG 0617)","volume":"99","author":"Jin","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018335539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814018335539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T23:03:01Z","timestamp":1605394981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814018335539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":38,"alternative-id":["S0167814018335539"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2018.10.029","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2018.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}